Applied DNA Sciences (NASDAQ:APDN) Stock Price Down 26.8%

Share on StockTwits

Applied DNA Sciences Inc (NASDAQ:APDN)’s stock price was down 26.8% during trading on Thursday . The company traded as low as $0.29 and last traded at $0.30, approximately 2,177,495 shares changed hands during trading. An increase of 332% from the average daily volume of 504,026 shares. The stock had previously closed at $0.41.

Separately, Maxim Group restated a “hold” rating on shares of Applied DNA Sciences in a report on Wednesday, June 12th.

The company has a current ratio of 0.81, a quick ratio of 0.66 and a debt-to-equity ratio of 2.82. The business’s fifty day moving average is $0.30 and its 200 day moving average is $0.50.

Applied DNA Sciences (NASDAQ:APDN) last issued its quarterly earnings data on Tuesday, August 13th. The technology company reported ($0.04) EPS for the quarter, topping analysts’ consensus estimates of ($0.06) by $0.02. Applied DNA Sciences had a negative net margin of 221.66% and a negative return on equity of 1,284.19%. The business had revenue of $2.05 million for the quarter.

In other Applied DNA Sciences news, major shareholder William W. Montgomery purchased 400,000 shares of the stock in a transaction on Thursday, August 22nd. The shares were purchased at an average cost of $0.27 per share, for a total transaction of $108,000.00. Following the purchase, the insider now owns 5,630,900 shares of the company’s stock, valued at $1,520,343. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 20.46% of the stock is currently owned by insiders.

Hedge funds have recently modified their holdings of the business. Capital Investment Advisors LLC acquired a new stake in Applied DNA Sciences in the 2nd quarter valued at $27,000. Wells Fargo & Company MN acquired a new stake in Applied DNA Sciences in the 2nd quarter valued at $54,000. Finally, Laurel Wealth Advisors Inc. bought a new position in shares of Applied DNA Sciences in the 1st quarter valued at about $71,000. Hedge funds and other institutional investors own 5.04% of the company’s stock.

About Applied DNA Sciences (NASDAQ:APDN)

Applied DNA Sciences, Inc develops and markets plat based or other DNA technology solution in the United States, Europe, and Asia. The company's supply chain security and product authentication solutions include SigNature molecular tags that are ingredients used to fortify brand protection efforts and strengthen supply chain security, as well as mark, track, and convict criminals; SigNature T molecular tags, which are tagging and authentication systems for use in brand protection efforts and raw material source compliance programs; and fiberTyping, a test of native cotton fiber DNA.

Featured Article: Debt-To-Equity Ratio

Receive News & Ratings for Applied DNA Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied DNA Sciences and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Anja Balfour Buys 5,000 Shares of Schroder Japan Growth Fund plc  Stock
Anja Balfour Buys 5,000 Shares of Schroder Japan Growth Fund plc Stock
Recent Investment Analysts’ Ratings Updates for Electrocomponents
Recent Investment Analysts’ Ratings Updates for Electrocomponents
Vertex Energy  Upgraded to “Buy” by Zacks Investment Research
Vertex Energy Upgraded to “Buy” by Zacks Investment Research
Wynn Macau  Stock Rating Reaffirmed by Zacks Investment Research
Wynn Macau Stock Rating Reaffirmed by Zacks Investment Research
Wipro  Upgraded by Zacks Investment Research to “Hold”
Wipro Upgraded by Zacks Investment Research to “Hold”
Zacks: Brokerages Anticipate Paycom Software Inc  Will Post Earnings of $0.69 Per Share
Zacks: Brokerages Anticipate Paycom Software Inc Will Post Earnings of $0.69 Per Share


© 2006-2019 Ticker Report